ACTRN12605000521628已完成不适用
A phase I study to compare the steady-state pharmacokinetics of estradiol following application to the abdomen of an Estradiol Metered-Dose Transdermal Spray (MDTS) and Estraderm 50 patches in healthy postmenopausal women, as hormone replacement therapy.
FemPharm Pty Ltd and/or Acrux DDS Pty Ltd0 个研究点目标入组 18 人开始时间: 2005年9月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 ot stated（—）
- 性别
- Female
入选标准
- •Healthy post-menopausal women
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
不适用
A study to evaluate the pharmacokinetic and pharmacodynamic equivalence of HSP-130 and United States-approved Neulasta (Registered Trademark) and European Union-approved Neulasta (Registered Trademark) administered as a single subcutaneous dose to healthy volunteers.The study will be conducted in healthy subjects. Neulasta is indicated for the treatment of cancer chemotherapy-induced neutropenia.Cancer - Any cancerACTRN12615001049561Hospira, Inc.150
已完成
不适用
A Phase 1 Study to Compare the Pharmacokinetics of CAL-101 Capsules to Tablets in Healthy Male Subjects.Blooddiseaseleukemia/lymophoma10047954NL-OMON35094Calistoga Pharmaceuticals Inc.15
招募中
不适用
Pharmacological study of chronomodulated capecitabine therapycancer, capecitabine, phase I, chronotherapy, biomarker, pharmacology, kanker, chronotherapie, fase INL-OMON24089etherlands Cancer Institute - Antoni van Leeuwenhoek Hospital42
招募中
不适用
Phase I pharmacological study of continuous and intermittent chronomodulated capecitabine therapymalignancies10027655cancerNL-OMON40756Antoni van Leeuwenhoek Ziekenhuis42
已完成
1 期
An interventional study to evaluate the effects of formulation and dose on the Pharmacokinetics (PK, the measure of how the human body prcessed a substance) of up to four Donezepil Transdermal Delivery System (TDS, a patch that delivers a drug) formulations (50 cm2 patch size), worn for seven days, applied to the backs of healthy female participants.Alzheimer’s DiseaseNeurological - Alzheimer's diseaseACTRN12616000348459INCResearch Australia Pty Ltd24